Literature DB >> 15687031

Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice.

R Reljic1, C Di Sano, C Crawford, F Dieli, S Challacombe, J Ivanyi.   

Abstract

SETTING: Dendritic cells (DC) could regulate between the protective and pathogenic immune responses following tuberculous infection. In this paper we investigated if their early infection in the lungs represents a plausible alternative to cross-priming with mycobacterial antigens acquired from infected macrophages.
OBJECTIVE: To determine the extent and time course of infection of lung DCs following intranasal inoculation of BALB/c mice with green fluorescent protein (GFP) tagged Bacillus Calmette-Guerin (BCG).
RESULTS: A fraction of GFP-BCG infected lung cells were classified as monocytic DCs with the CD11c+IA+33D1+CD8a- phenotype. These cells represented 5-18% of the total GFP+ cells, the bulk of which were macrophages. The infected DCs could be separated by cell size into two fractions with similar cell surface staining properties during the 2-72 h period after infection. An unexpected difference was observed for the time course of infection between DCs and macrophages: DC infection peaked at 48 h followed by decline at 72 h, while the proportion of infected macrophages remained steady during the same period.
CONCLUSION: The presented results are direct evidence that monocytic DCs are recruited to the lungs and take up live bacilli within 48 h of intranasal infection with GFP-BCG. This finding is pertinent for the regulation of pulmonary and systemic immune responses and possibly for the dissemination of mycobacterial infection by DCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15687031     DOI: 10.1016/j.tube.2004.09.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  14 in total

1.  Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.

Authors:  Tuhina Gupta; Monica LaGatta; Shelly Helms; Rebecca L Pavlicek; Simon O Owino; Kaori Sakamoto; Tamas Nagy; Stephen B Harvey; Mark Papania; Stephanie Ledden; Kevin T Schultz; Candace McCombs; Frederick D Quinn; Russell K Karls
Journal:  Tuberculosis (Edinb)       Date:  2018-10-19       Impact factor: 3.131

2.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.

Authors:  Clifford V Harding; W Henry Boom
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

Review 5.  The role of dendritic cells in mycobacterium-induced granulomas.

Authors:  Heidi A Schreiber; Matyas Sandor
Journal:  Immunol Lett       Date:  2010-01-04       Impact factor: 3.685

6.  Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.

Authors:  Heidi A Schreiber; Paul D Hulseberg; JangEun Lee; Jozsef Prechl; Peter Barta; Nora Szlavik; Jeffrey S Harding; Zsuzsanna Fabry; Matyas Sandor
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

7.  Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection.

Authors:  Nicole D Pecora; Scott A Fulton; Scott M Reba; Michael G Drage; Daimon P Simmons; Nancy J Urankar-Nagy; W Henry Boom; Clifford V Harding
Journal:  Cell Immunol       Date:  2008-08-30       Impact factor: 4.868

8.  TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.

Authors:  Michael G Drage; Nicole D Pecora; Amy G Hise; Maria Febbraio; Roy L Silverstein; Douglas T Golenbock; W Henry Boom; Clifford V Harding
Journal:  Cell Immunol       Date:  2009-04-11       Impact factor: 4.868

9.  A novel human IgA monoclonal antibody protects against tuberculosis.

Authors:  Sucharitha Balu; Rajko Reljic; Melanie J Lewis; Richard J Pleass; Richard McIntosh; Cees van Kooten; Marjolein van Egmond; Stephen Challacombe; Jenny M Woof; Juraj Ivanyi
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

10.  Granuloma transplantation: an approach to study mycobacterium-host interactions.

Authors:  Jeffrey S Harding; Heidi A Schreiber; Matyas Sandor
Journal:  Front Microbiol       Date:  2011-12-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.